FDA’s emerging framework to reduce animal testing: Implicati...
Exploring the strategic shift toward reducing reliance on non-human primates (NHPs) and other animal species in R&D.
Newsletters and Deep Dive digital magazine
Exploring the strategic shift toward reducing reliance on non-human primates (NHPs) and other animal species in R&D.
There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.
Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.
The call lasted ten minutes. My manager was apologetic. HR was professional.
Perspective Therapeutics is advancing image‑guided, targeted alpha‑particle therapies (TATs). We spoke to Thijs Spoor at ESMO 2025 to find out more.
Editor's Picks
Newsletters and Deep Dive
digital magazine